On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare’s most fundamental tools.

Insulin pump therapy, also known as continuous subcutaneous ... including Roche Diagnostics, Sanofi, Abbott, and Medtronic. G.A.F. is President and CEO of Kinexum, which advises multiple health ...

One system consisted of a Stockert SIII roller pump (Sorin Group USA, Arvada, CO) with a Tygon S-95 tubing raceway (Saint-Gobain Performance Plastics, Portage, WI), a Medtronic 0800 or 1500 ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report).

A Beverly Hills surgeon is suing Medtronic claiming patent infringement of her hernia repair mesh product. It's the latest in ...

Analysts on Wall Street project that Medtronic (MDT) will announce quarterly earnings of $1.24 per share in its forthcoming report, representing a decline of 0.8% year over year. Revenues are ...